{
    "nctId": "NCT03619707",
    "officialTitle": "Oral Dydrogesterone Versus Vaginal Progesterone in the Luteal Phase Support in Cryo-warmed Embryo Transfer Cycles: Randomized Controlled Trial",
    "genderBased": true,
    "inclusionCriteria": "* Normal uterine cavity\n* Normal Hormonal investigation: TSH,PRL,FBS\n* Frozen embryo transfer cycles: at least 2 embryos\n* Primary or secondary infertility: tubal occlusion, male factor, unexplained, endometriosis, ovarian factors...\n* Body mass index (BMI) \u226518 to \u226430 kg/m2\n* Must be FEMALE\n* Must have minimum age of 18 Years\n* Must have maximum age of 38 Years",
    "exclusionCriteria": "* Preexisting untreated medical condition (thyroid disease, diabetes mellitus, hypertension, pulmonary conditions, cardiac condition...)\n* History of three or more consecutively failed In Vitro Fertilization (IVF) cycles after embryo transfer\n* History of three or more miscarriages\n* Previous allergy reactions to progesterone products"
}